HOME >> MEDICINE >> NEWS
Cure Rate Soars For Some AML Patients Receiving High-Dose Drug

COLUMBUS, Ohio -- A drug given at levels substantially higher than the standard dose can cure nearly five times as many patients who have a certain type of acute myeloid leukemia (AML), new research shows.

The study revealed that 78 percent of patients with “core binding factor” AML who received the drug cytarabine at high dose were in complete remission five years after treatment (and therefore potentially cured) compared to only 16 percent who received the standard dose.

“It is truly remarkable to achieve a cure rate of over 75 percent in a subgroup of adult leukemia patients; this rate approaches that for some types of childhood leukemia,” said Clara Bloomfield, director of Ohio State University's Comprehensive Cancer Center and William G. Pace III Professor of Cancer Research.

“Because high-dose cytarabine is quite toxic, especially for older people, we want to use it only with those patients who will benefit. These results tell us which patients we can cure, and which ones should receive other therapy.”

The finding is considered particularly strong because the study had followed patients for more than seven years after treatment; most such studies rely on models to project estimates of five-year remission rates.

The study, which was led by Bloomfield, appeared in the September issue of the journal Cancer Research. It involved 285 newly diagnosed AML patients aged 16 and older who were in remission. During the second phase of their treatment, a phase known as “intensification therapy,” the patients were randomly assigned to receive cytarabine at either standard dose (100 milligrams per square meter
'"/>

Contact: Clara Bloomfield
bloomfield-1@medctr.osu.edu
614-293-7518
Ohio State University
29-Oct-1998


Page: 1 2 3

Related medicine news :

1. Patients newly diagnosed with HIV are more likely to enter outpatient care with case management
2. Patients with cancer have highly increased risk for blood clots
3. Patients with previous heart attacks may not benefit from pacemaker implant
4. Patients with cancer detected on screening mammography undergo less toxic treatment
5. Patients with moderate or severe hand dermatitis responsive to drug therapy
6. Patients with abdominal trauma at risk for intra-abdominal infections following surgery
7. Patients who are intubated prior to hospital arrival fare worse find Pitt researchers
8. Patients undergoing weight loss surgery have high rates of H pylori bacteria
9. Patients with chronic sinus do not necessarily develop antibiotic resistance
10. Plastic surgeons honor Patients of Courage overcoming difficult obstacles, inspiring others
11. Patients with severe depression improve using guidelines developed by UT Southwestern researchers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cure Rate Soars For Some AML Patients Receiving High Dose Drug

(Date:4/27/2015)... PREVENT Life Safety, America’s premier provider of life ... addition of an account manager in Houston. In order ... customer base, Curtis Rice, an experienced sales professional, has ... Curtis has been added to the team to generate ... area and beyond. , Curtis brings with ...
(Date:4/27/2015)... 27, 2015 Health conscious businesses in ... first-of-its-kind bakery right on their doorstep, which will offer ... on restrictive and low-carbohydrate diets. This nut-based ... starch free, and will use only natural sweeteners like ... 2015, strives to provide specialty food that is currently ...
(Date:4/27/2015)... April 27, 2015 Jvion, the Atlanta-based ... Atlanta Pacesetter and recognized as one of the top ... award, which is presented by the Atlanta Business Chronicle, ... accelerate Atlanta’s status as an economic capital and employment ... success is spurred by the growing need to improve ...
(Date:4/26/2015)... York (PRWEB) April 26, 2015 ... 21, 2015 in the U.S. District Court, Northern ... lawsuits ( http://www.testosteronelawsuithub.com/ ) have been consolidated ... to court documents, matters addressed included the intention ... of claims involving their products on preemption grounds, ...
(Date:4/26/2015)... has released a new blog post explaining how to find ... to find low cost auto insurance is by comparing quotes. ... in a simple and convenient way. It is no longer ... prices. All the details are now freely available to anyone ... possible to compare online car insurance quotes on a single ...
Breaking Medicine News(10 mins):Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2Health News:Nourish Bakery Serves Up Healthy Eating in Huntsville, Alabama 2Health News:Jvion Named to Top 40 Atlanta 2015 Pacesetters 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Finding Low Cost Auto Insurance - An Online Guide Provides Tips 2
(Date:4/27/2015)... 27, 2015 TWi Pharmaceuticals, Inc. ("TWi") ... Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda ... Pharmaceuticals America, Inc. (individually and collectively, "Takeda") to ... to TWi,s generic dexlansoprazole delayed release capsules for ... dosage strengths. An Abbreviated New Drug Application for TWi,s ...
(Date:4/25/2015)...  With the introduction of Elekta,s new Leksell Gamma ... now available for more patients with a wider variety ... radiosurgery system for the brain, integrates advanced motion management, ... of Gamma Knife radiosurgery. Elekta unveiled Leksell Gamma Knife ... in Barcelona . "This ...
(Date:4/24/2015)... , April 24, 2015  Perrigo Company plc ("Perrigo" ... rejection of the unsolicited offer from Mylan NV ("Mylan") ... outstanding shares of Perrigo for $60.00 per share in ... Perrigo share (the "Offer").  The Board ... share significantly undervalued the Company and its future growth ...
Breaking Medicine Technology:TWi Announces Settlement with Takeda on Dexilant(R) Litigation 2New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4
Cached News: